β-Casomorphin (1-3), amide is a peptide fragment of β-Casomorphin with 3 amino acid.
β-Casomorphin (1-3), amide is a short bioactive peptide fragment derived from the enzymatic digestion of bovine casein, specifically representing the N-terminal tripeptide sequence of the larger β-casomorphin family. As an amide-terminated peptide, it exhibits enhanced metabolic stability and unique receptor-binding properties compared to its free acid counterpart. This compound is of significant interest in peptide biochemistry due to its opioid-like activity, selectivity for opioid receptors, and its role as a model system for studying peptide-receptor interactions. Its well-defined sequence and physicochemical properties make it a valuable tool for researchers investigating peptide structure-activity relationships, receptor pharmacology, and peptide-based signaling mechanisms.
Receptor binding studies: β-Casomorphin (1-3), amide is widely utilized in receptor binding assays to probe the specificity and affinity of endogenous and synthetic peptides for opioid receptors, particularly the μ-opioid subtype. Its short sequence and amide modification allow for the detailed analysis of ligand-receptor interactions, supporting the development of new pharmacological probes and the elucidation of opioid receptor activation mechanisms. By serving as a reference ligand or competitor in binding studies, it contributes to the mapping of binding sites and the understanding of structural determinants governing receptor selectivity.
Peptide structure-activity relationship (SAR) investigations: In peptide research, β-Casomorphin (1-3), amide is frequently employed as a model compound to explore the effects of sequence truncation, N-terminal modifications, and C-terminal amidation on biological activity. Its defined structure enables systematic SAR studies, providing insights into how minor sequence alterations influence receptor affinity, signaling potency, and metabolic stability. Such investigations are critical for the rational design of novel bioactive peptides and peptide-mimetic therapeutics.
Enzymatic degradation and metabolic stability research: The compound's resistance to exopeptidase-mediated hydrolysis, conferred by its amide terminus, makes it a useful substrate for studying peptide degradation pathways and the influence of terminal modifications on peptide half-life. Researchers use this tripeptide to assess the activity of peptidases, characterize metabolic profiles, and evaluate strategies to enhance peptide stability for research and industrial applications. Its utility extends to comparative studies with non-amidated analogs, highlighting the impact of C-terminal modifications on peptide fate in biological systems.
Analytical method development: β-Casomorphin (1-3), amide serves as a standard or reference material in the development and validation of analytical techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and capillary electrophoresis. Its well-characterized structure and physicochemical properties facilitate the optimization of detection protocols, quantification assays, and peptide identification workflows. This role is particularly valuable in quality control settings, peptide mapping, and the analysis of complex protein hydrolysates.
Cell signaling and functional assays: The peptide is employed in in vitro systems to investigate opioid receptor-mediated signaling pathways, including G protein activation, second messenger production, and downstream cellular responses. Its defined activity profile allows researchers to dissect the functional consequences of receptor engagement, evaluate antagonist or agonist interactions, and model neuropeptide signaling in neural and peripheral tissues. Such studies advance the understanding of peptide-mediated communication and the cellular mechanisms underlying opioid receptor function.
Through these diverse applications, β-Casomorphin (1-3), amide supports a wide range of experimental approaches in peptide science, receptor pharmacology, analytical chemistry, and cell signaling research, making it an indispensable tool for advancing biochemical knowledge and experimental innovation.
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
2. Cationic cell-penetrating peptides are potent furin inhibitors
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.